Does not apply. Because this study is not about diseases..
Conditions
Interventions
Intervention 1: The first intervention group is the group in which PRP is infused only once for the patient. The initial preparation steps of the control and intervention groups are performed in the s
Sponsors
Fasa University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Satisfaction to enter the study Age <40 years Body mass index (BMI) <30 kg / m2
Exclusion criteria
Exclusion criteria: Existence of any uterine abnormalities (congenital or acquired) Existence of any uterine abnormalities (congenital or acquired) Uncontrolled hormonal disease ( prolactinemia or thyroid disease) and endometriosis Blood diseases (hemoglobin <9.0 g / dl and platelet count <100,000 per microliter) Chromosomal defects in the patient or spouse Lack of quality blastocysts (Grade A or B according to embryological score) for transmission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study has only one outcome and the end result is a pregnancy test. At the end of the cycle, pregnancy is determined by laboratory evaluation of serum ß-HCG and the presence of fetal heartbeat on transvaginal ultrasound 2 weeks and 5 weeks after embryo transfer, respectively. Timepoint: evaluation of serum ß-HCG and the presence of fetal heartbeat on transvaginal ultrasound 2 weeks and 5 weeks after embryo transfer. Method of measurement: Transvaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZeinab Shahryari
Shiraz University of Medical Sciences
Outcome results
None listed